Analyst Ratings For Stryker
Portfolio Pulse from Benzinga Insights
Analyst ratings for Stryker (NYSE:SYK) show a mix of bullish to bearish sentiments, with recent updates indicating a positive trend. The average 12-month price target for SYK has been raised to $380.44, reflecting a 5.5% increase from the previous target. Analysts from firms like Piper Sandler, Stifel, and Citigroup have raised their price targets, citing the company's strong financial health, market leadership in medical equipment, and positive revenue growth. Stryker's market capitalization and financial metrics such as net margin, ROE, and ROA surpass industry averages, indicating robust financial performance and investor confidence.
May 01, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Stryker's positive analyst ratings and increased price targets reflect strong financial health and market leadership. Recent financial metrics indicate robust performance, supporting investor confidence.
The unanimous positive revisions in Stryker's price targets by analysts from reputable firms, coupled with the company's superior financial metrics and market position, suggest a strong short-term bullish sentiment. The increase in the average price target, supported by Stryker's revenue growth, net margin, ROE, and ROA outperforming industry averages, indicates a positive outlook that could drive investor interest and potentially uplift the stock price in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100